MedTrace Logo

AneuRx Post Market Study in the Treatment of AAA

NCT00604552 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 349

Last updated 2021-10-29

Study results available
· View outcomes & findings →

Summary

The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body. An aneurysm is a weakening in the artery wall that will become a bulge in the aorta. If left untreated, this bulge may continue to grow larger and may rupture (break open) with fatal consequences. Abdominal aortic aneurysm (AAA) is a life-threatening lesion that has been treated in recent year via endovascular repair.

The purpose of this study is to monitor the long term performance of the AneuRx Stent Graft Systems.

Conditions

  • Abdominal Aneurysm

Interventions

DEVICE

AneuRx Stent Graft

Abdominal Aortic Aneurysm Repair

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Medtronic Cardiovascular · Medtronic

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Primary Completion
2008-02-29
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00604552 on ClinicalTrials.gov